CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Rochester, Minnesota, United States and 44 other locations
with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes...
Phase 3
Rochester, Minnesota, United States and 159 other locations
fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...
Phase 3
Rochester, Minnesota, United States and 65 other locations
The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly co...
Phase 3
Rochester, Minnesota, United States and 183 other locations
This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combi...
Phase 3
Rochester, Minnesota, United States and 27 other locations
The primary objective of the FALCON study is to evaluate the efficacy of KL1333 on selected disease manifestations of primary mitochondrial disease (...
Phase 2
Rochester, Minnesota, United States and 54 other locations
This is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully...
Phase 2
Rochester, Minnesota, United States and 47 other locations
This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...
Phase 2
Rochester, Minnesota, United States and 67 other locations
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Phase 3
Rochester, Minnesota, United States and 467 other locations
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes...
Phase 3
Rochester, Minnesota, United States and 556 other locations
Clinical trials
Research sites
Resources
Legal